Brief: Sosei Heptares Announces Antitrust Clearance Of License Agreement With Neurocrine Biosciences
23/12/2021 23:29
Dec 23 (Reuters) - Sosei Group Corp 4565.T :
* SOSEI HEPTARES ANNOUNCES ANTITRUST CLEARANCE OF LICENSE
AGREEMENT WITH NEUROCRINE BIOSCIENCES
Source text for Eikon: ID:nGNX3bSlpj
Further company coverage: 4565.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nxera Pharma
See all newsNxera Pharma Submits Marketing Authorization Application For Vamorolone In South Korea For Treatment Of Duchenne Muscular Dystrophy
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Nxera Pharma - Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-Pacific Markets
Brief: Nxera Announces Successful Resolution Of Minig Patent Infringement Action
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up